VANCOUVER, British Columbia--(BUSINESS WIRE)--Nov. 7, 2005--Inflazyme Pharmaceuticals Ltd. (TSX:IZP) today announced its second quarter financial results for the period ended September 30, 2005, which reflect the recent corporate reorganization that generated approximately $7 million in non-dilutive funding.
